TRUPANION, INC.

Listed Company

TRUPCIK 0001371285NasdaqLarge AcceleratedHospital & Medical Service PlansDelawareFY ends Dec 31

Period

FY 2025

Revenue

$1.44B

Net Income

—

Total Assets

$915.04M

Equity

$383.94M

Shares Out

43.62M

Op. Cash Flow

$89.49M

Business

Trupanion, Inc. provides medical insurance for cats and dogs through a data-driven, vertically integrated insurance business. It offers subscription medical insurance products priced for each pet’s unique characteristics, proprietary software that enables direct payment to veterinarians, and complementary offerings marketed through third parties. The company operates two reporting segments: a subscription business focused on direct-to-consumer and Powered by Trupanion products, and an other business comprising business-to-business offerings with third-party partners. Trupanion distributes products across the United States, Canada, parts of Continental Europe, and Australia via veterinarians, retail, worksite channels, and online.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	1,439	1,286	1,109	905	699
Veterinary invoice expense	1,029	949	831	650	486
Other cost of revenue	179	158	147	133	109
Total cost of revenue	1,208	1,107	978	783	595
Technology and development	38	31	21	25	17
General and administrative	77	64	60	39	32
New pet acquisition expense	85	71	77	90	79
Goodwill, Impairment Loss	1	5	0	0	—
Depreciation and amortization	16	16	12	11	12
Total operating expenses	217	188	171	165	139
Loss from investment in joint venture	−305,000	−182,000	−219,000	−253,000	−171,000
Operating income (loss)	14	−10	−41	−43	−35
Interest expense	14	14	12	4	10,000
Other (income), net	−22	−14	−8	−3	0
Income (loss) before income taxes	22	−10	−45	−44	−35
Income tax expense (benefit)	3	−5,000	−342,000	476,000	310,000
Net income (loss)	19	−10	−45	−45	−36
Earnings Per Share, Basic	0.45	−0.23	−1.08	−1.1	−0.89
Earnings Per Share, Diluted	0.45	−0.23	−1.08	−1.1	−0.89
Weighted Average Number of Shares Outstanding, Basic	43	42	41	41	40
Weighted Average Number of Shares Outstanding, Diluted	44	42	41	41	40

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	138	160	148	66	87
Short-term investments	233	147	130	157	126
Accounts and other receivables	302	274	268	232	165
Prepaid expenses and other assets	18	16	17	14	12
Total current assets	691	597	562	469	391
Restricted cash	33	39	23	19	13
Long-term investments	983,000	373,000	13	8	7
Property, equipment, and internal-use software, net	105	102	104	91	78
Intangible assets, net	24	13	19	24	23
Other long-term assets	21	18	19	19	18
Goodwill	39	37	44	42	33
Total assets	915	807	783	672	563
Accounts payable	16	12	11	9	9
Accrued liabilities and other current liabilities	57	33	34	33	28
Reserve for veterinary invoices	56	52	63	44	40
Deferred revenue	271	252	235	203	147
Long-Term Debt, Current Maturities	10	1	1	1	0
Total current liabilities	410	350	344	290	224
Long-Term Debt	102	128	128	68	0
Deferred tax liabilities	2	2	3	3	3
Other liabilities	18	4	4	5	4
Total liabilities	531	484	479	366	230
Common stock: $0.00001 par value per share	0	0	0	0	0
Preferred stock: $0.00001 par value per share	0	0	0	0	0
Additional paid-in capital	605	568	536	500	467
Accumulated other comprehensive income (loss)	2	−3	403,000	−6	3
Accumulated deficit	−206	−226	−216	−172	−127
Treasury stock, at cost	−17	−17	−17	−17	−11
Total stockholders' equity	384	323	304	305	332
Total liabilities and stockholders equity	915	807	783	672	563
Common Stock, Par or Stated Value Per Share	0	0	0	0	0
Common Stock, Shares Authorized	100	100	100	100	100
Preferred Stock, Shares Issued	0	0	0	0	0
Preferred Stock, Shares Authorized	10	10	10	10	10
Preferred Stock, Par or Stated Value Per Share	0	0	0	0	0

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Stock-based compensation expense	38	33	33	33	28
Nonmonetary Transaction, Gain (Loss) Recognized on Transfer	−8	0	0	—	—
Other, net	2	−2	1	1	−2
Accounts and other receivables	−27	−7	−35	−67	−66
Prepaid expenses and other assets	−1	3	−2	−5	−3
Accounts payable, accrued liabilities, and other liabilities	26	2	2	3	9
Reserve for veterinary invoices	4	−11	19	4	11
Deferred revenue	19	17	33	56	54
Net cash provided by operating activities	89	48	19	−8	7
Purchases of investment securities	−256	−133	−166	−273	−96
Maturities and sales of investment securities	173	128	190	239	58
Purchases of property, equipment, and internal-use software	−14	−10	−18	−17	−12
Other	2	2	2	−2	−2
Net cash provided by (used in) investing activities	−96	−13	8	−68	−52
Proceeds from exercise of stock options	2	752,000	3	2	4
Shares withheld to satisfy tax withholding	−4	−3	−2	−4	−5
Proceeds from debt financing, net of financing fees	114	0	60	69	0
Repayment of debt financing	−134	−1	−2	−571,000	0
Other	−614,000	−840,000	−378,000	0	0
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total	−23	−4	59	61	−1
Net change in cash, cash equivalents, and restricted cash	−28	29	86	−16	−45
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	1	−2	424,000	−1	252,000
Interest paid	13	13	12	3	16,000
Purchases of property, equipment, and internal-use software included in accounts payable and accrued liabilities	129,000	534,000	887,000	1	729,000
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	14	0	0	—	—
Noncash or Part Noncash Acquisition, Description	15	0	0	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro